Skip to main content

Table 4 Estimates of effects (with 95 % credible intervals) and confidence ratings for comparisons of therapeutic agents for the treatment of idiopathic pulmonary fibrosis (IPF) on the outcome severe adverse events (SAEs)

From: Treatment of idiopathic pulmonary fibrosis: a network meta-analysis

  1. OR, Odds ratio
  2. 1 Certainty lowered for imprecision
  3. 2 Certainty lowered for individual study risk of bias
  4. 3 Certainty lowered two levels for imprecision
  5. 4 Certainty lowered for indirectness
  6. GRADE Working Group grades of evidence – High quality: Further research is very unlikely to change our confidence in the estimate of effect; Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate; Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate; Very low quality: We are very uncertain about the estimate
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us